Clinical symptom score and risk factors for predicting post-acute sequelae of SARS-CoV-2 infection in children hospitalized with COVID-19 in Taiwan. [PDF]
Lai HC +11 more
europepmc +1 more source
Azvudine for COVID-19 in Kidney Transplant Recipients: A Real-World Observational Study of Long-Term Renal Outcomes. [PDF]
Li X +10 more
europepmc +1 more source
Modernising antiviral drug discovery: harnessing medicinal plants through machine learning and metabolomics to target the SARS-CoV-2 main protease. [PDF]
Msobo A +4 more
europepmc +1 more source
Potential Drug-Drug Interactions With Nirmatrelvir/Ritonavir Among Long-Term Care Facility Residents. [PDF]
Khan MA +8 more
europepmc +1 more source
Nirmatrelvir/Ritonavir Efficacy in Immunocompetent Patients with Confirmed Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2: An Updated Systematic Review and Meta-analysis. [PDF]
Khani E +6 more
europepmc +1 more source
Visualization of FDA Adverse Drug Reaction Reports: Development and Usability Study of the VisDrugs Web Server. [PDF]
Yang R, Yin N, Zhang Y, Faiola F.
europepmc +1 more source
Development and Validation of an Electronic Health Record-Derived Prediction Model for Preventing COVID-19 Hospitalization and Death. [PDF]
Coley RY +12 more
europepmc +1 more source
Effectiveness of Nirmatrelvir/Ritonavir in Unvaccinated COVID-19 Patients Treated in the Emergency Department: A Retrospective Propensity-Matched Cohort Analysis. [PDF]
Jehle DVK +5 more
europepmc +1 more source
Disparate SARS-CoV-2 Infection Outcomes Abound, but What Makes SARS-CoV-2 Bound for Rebound? [PDF]
Sheahan TP.
europepmc +1 more source
Characteristics of outpatient nirmatrelvir/ritonavir recipients during the 2022/2023 era in Alberta, Canada: A retrospective observational population-based study. [PDF]
Vu K +10 more
europepmc +1 more source

